cephalosporin c has been researched along with tobramycin in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 103 (52.82) | 18.7374 |
| 1990's | 51 (26.15) | 18.2507 |
| 2000's | 22 (11.28) | 29.6817 |
| 2010's | 15 (7.69) | 24.3611 |
| 2020's | 4 (2.05) | 2.80 |
| Authors | Studies |
|---|---|
| Weinstein, AJ | 1 |
| Arbeter, AM; Plotkin, SA | 1 |
| Kohl, S; Pickering, LK | 1 |
| Carret, JP; de Mourgues, G; Fischer, LP; Gonon, GP; Vulliez, Y | 1 |
| Fieker, DH; McHenry, MC | 1 |
| Ball, AP; Gray, JA; Murdoch, JM | 1 |
| Fabre, S; Jennis, F; Vincent, PC | 1 |
| Balcke, P; Graninger, W; Kopsa, H; Pils, P; Schimatzek, A; Schmidt, P; Zazgornik, J | 1 |
| Africa, CW; Appelbaum, PC; Block, C; Botha, P; Crewe-Browne, H; de Klerk, HC; du T Naudé, W; Fernandez, A; Forder, A; Hyland, J; Jooste, PJ; Koornhof, HJ; Neiteler, BF; Robins-Browne, R; Robinson, R; van den Ende, J; van Rensburg, AJ | 1 |
| Mandell, GL; Verklin, RM | 1 |
| Gentry, LO | 1 |
| Hopefl, AW | 1 |
| Lismont, MJ; Schoutens, E; Van der Linden, MP; Yourassowsky, E | 1 |
| Bartlett, M; Crane, JK; Griffin, PS; Miller, MA; Yousuf, M | 1 |
| Ratschow, R | 1 |
| Jedlicková, Z | 1 |
| Abramson, N; Fee, WE; Goode, RL; Levine, P | 1 |
| Bodey, GP; Ketchel, SJ; Rodriguez, V | 1 |
| Gayer, J | 1 |
| Bodey, GP; Ketchel, S; Rodriguez, V | 1 |
| Noone, P | 1 |
| Knothe, H; Sietzen, W | 1 |
| McAllister, TA | 1 |
| Broddle, WD; Owen, NV; Turnipseed, SA; Wold, JS | 1 |
| Bourque, G; Charrel, CT; Gouin, F; Morel, M; Pedrant, G; Seguin, F | 1 |
| Kanazawa, Y; Kuramata, T | 1 |
| Neu, HC | 1 |
| Hasuike, T; Hirai, M; Inoue, T; Misu, K; Nakao, Y; Ohira, H; Ota, K; Tanaka, K; Yamane, T; Yasui, Y | 1 |
| Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
| Shapiro, SA | 1 |
| Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
| Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME | 1 |
| Daschner, F; Kropec, A | 1 |
| Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
| Giamarellou, H | 1 |
| de Jonge, MJ; de Ridder, CM; Degener, JE; Dzoljic-Danilovic, G; Horrevorts, AM; Kerrebijn, KF; Michel, MF; Poot, MC | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Chin, NX; Jules, K; Labthavikul, P; Neu, HC | 1 |
| Brus-Weijer, L; Michel, MF; Wagenvoort, JH | 1 |
| Bezwoda, WR; Cassel, R; Derman, DP; Perkins, S | 1 |
| Francisco, GE; McCall, CY; Spruill, WJ | 1 |
| Aronoff, SC; Klinger, JD | 1 |
| Gaudin, H; Lafaix, C; Mariel, C | 1 |
| Bakken, JS; Hulsund, M | 1 |
| Hess, H; Heynold, FT; Mondorf, AW; Scherberich, JE; Schoeppe, W | 1 |
| Heinert, G; Mondorf, AW; Scherberich, JE; Schoeppe, W | 1 |
| Cynamon, MH; Granato, PA | 1 |
| Johnson, CE; Pennington, JE; Platt, R | 1 |
| Abbruzzese, JL; Laskin, OL; Lipsky, JJ; McGaughey, MD; Rocco, LE; Skubitz, KM | 1 |
| Carson, HB; Heller, AS; Koch, TB; Schentag, JJ; Walczak, P | 1 |
| Frear, RS | 1 |
| Lascola, RJ; Reitberg, DP; Schentag, JJ; Van Tyle, JH; Walczak, P; Wels, PB | 1 |
| Fitzpatrick, SB; Rosenstein, BJ | 1 |
| Knothe, H | 1 |
| Shah, PM; Stille, W; Troche, G | 1 |
| Murray, PR | 1 |
| Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
| Klastersky, J; Lagast, H; Zinner, SH | 1 |
| Drew, WL; Mintz, L | 1 |
| Duma, RJ | 1 |
| Frimodt-Møller, PC; Madsen, PO | 2 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB; Valdivieso, M | 1 |
| Jelinek, R; Schoengut, H | 1 |
| Alfredson, H; Ericsson, A; Malmborg, AS; Strandvik, B | 1 |
| Christensen, HO; Høiby, N; Koch, C; Møller, AF; Møller, S; Permin, H | 1 |
| Fleming, PC; Gold, R; Isles, A; Jin, E; Levison, H | 1 |
| Connor, PJ; David, TJ; Phillips, BM | 1 |
| Duerden, BI; Lilleyman, JS; Morgan, G | 1 |
| Feist, H; Muhar, F; Vetter, N; Williams, KJ | 1 |
| Darbyshire, PJ; Mott, MG; Oakhill, A; Pedler, SJ; Speller, DC; Williamson, PJ | 1 |
| Cox, CE | 1 |
| Bellingham, AJ; Bennet, C; Brada, M; Hart, CA; Reilly, JT | 1 |
| Duperval, R; Feld, R; Fong, I; Mandell, LA; Nicolle, LE; Robson, HG; Ronald, AR; Vincelette, J | 1 |
| Blanco, JD; Castaneda, YS; Duff, P; Gibbs, RS; St Clair, PJ | 1 |
| Alestig, K; Rödjer, S; Sandberg, T; Trollfors, B; Westin, J | 1 |
| Aronoff, GR; Blase, DK; Luft, FC; Nierste, DM; Visscher, DW; Walker, NA | 1 |
| Ericsson, CD; Rowlands, BJ | 1 |
| Heilesen, AM; Høiby, N; Koch, C; Permin, H | 1 |
| Chandrasekar, PH; Francisco, M; LeFrock, JL; Rolston, KV; Schell, RF | 1 |
| Drake, TA; Hackbarth, CJ; Rusnak, MG; Sande, MA | 1 |
| Miles, H; Pavillard, ER | 1 |
| Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
| Mirrett, S; Reimer, LG; Reller, LB | 1 |
| Butler, TF; Mahoney, DF; Turner, JR | 1 |
| Arimori, S; Komatsuda, M; Nagao, T; Nozaki, H; Yamauchi, K | 1 |
| Harada, Y; Okamoto, T; Teshima, K | 1 |
| Coppens, L; Hanson, B; Klastersky, J | 1 |
| DeGirolami, P; Eliopoulos, GM; Gardella, A; Moellering, RC | 1 |
| Flensborg, EW; Høiby, N; Szaff, M | 1 |
| Ambrose, PJ; Harralson, AF; Tindula, RJ | 1 |
| Daschner, F | 1 |
| Burghoffer, B; Daguet, GL; Petit, JC; Richard, G | 1 |
| Crenshaw, C; Glanges, E; McReynolds, DB; Webber, C | 1 |
| Breyer, S; Graninger, W; Pauser, G; Pichler, H; Pirich, U | 1 |
| Coppens, L | 1 |
| Edwards, DJ; Schentag, JJ | 1 |
| Gentry, LO; Martin, MD; Smythe, J; Wood, BA | 1 |
| Azzoni, P | 1 |
| Böhni, E; Seiler, W; Stähelin, HB | 1 |
| Yaffe, SJ | 1 |
| Federspil, P | 1 |
| Iakushkina, IV; Malkova, IV; Shapovalova, SP | 1 |
| Appleby, DH; John, JF | 1 |
| Penner, JL; Preston, MA | 1 |
| Luper, WE; Martin, RF; Phillips, LE; Rogers, TE | 1 |
| Alfonso, E; Fink, NE; Maguire, MG; McDonnell, P; O'Brien, TP | 1 |
| Brandis, M; Burghard, R; Gordjani, N; Leititis, JU; Mathäi, H; Mergehenn, G; Müller, D | 1 |
| Fukuhara, J; Kouda, M; Matsuzaki, H; Tamura, K; Udagawa, I | 1 |
| D'Souza, CR; Hopp, PG; Kilam, S | 1 |
| Baker, RS; Casey, R; Flowers, CW; Fong, DS; Wilson, MR | 1 |
| Hove, H; Mortensen, PB; Tvede, M | 1 |
| Audicana, M; Del Pozo, MD; Fernandez De Corres, LF; Fernandez, E; Munoz, D | 1 |
| Ballow, CH; Forrest, A; Kashuba, AD | 1 |
| Bosso, JA; Burgess, DS; Manduru, M; White, RL | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
| Dalla Costa, T; Derendorf, H | 1 |
| Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI | 1 |
| Schneeberger, P; Sluiter, E; Spanjaard, L; van Doorn, LJ | 1 |
| Christensen, JM; Hollingshead, N; Murdane, SB; Smith, BB | 1 |
| den Hollander, JG; Horrevorts, AM; Mouton, JW; van Goor, ML; Verbrugh, HA | 1 |
| Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI | 1 |
| Albrecht, H; Bubert, A; Elsner, HA; Laufs, R; Mack, D; Sobottka, I | 1 |
| Donaldson, K; Girard, LJ | 1 |
| Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W | 1 |
| Alestig, K; Eilard, T; Ek, E; Hebelka, M; Johansson, E; Olinder-Nielsen, AM; Sandberg, T | 1 |
| Cormio, L; La Forgia, D; La Forgia, P; Ruutu, M; Siitonen, A | 1 |
| Canis, F; Cavallo, JD; Husson, MO | 1 |
| Büyükpamukçu, N; Ciftci, AO; Hiçsonmez, A; Tanyel, FC | 1 |
| Majtán, V; Majtánová, L | 1 |
| Berman, SJ; Farkas, SA; Geckler, RW; Sieger, B | 1 |
| Bernich, P; Cantaluppi, MC; Laudon, A; Lupo, A; Marcantoni, C; Maschio, G; Mosconi, G; Rugiu, C | 1 |
| Battles, A; Liu, QF; Liu, W; Louie, A; Miller, DA; Miller, MH; Sucke, AC | 1 |
| Donzis, PB | 1 |
| Armstrong, VW; Binder, C; Binder, L; Erichsen, N; Hiddemann, W; Menke, CF; Oellerich, M; Schiel, X; Schüttrumpf, S; Unterhalt, M | 1 |
| Barbaglio, A; Cortelazzi, R; Martignoni, G; Nocini, PF | 1 |
| Charlton, JF; Dalla, KP; Kniska, A | 1 |
| Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
| den Hollander, JG; Mouton, JW; Verbrugh, HA | 1 |
| Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
| Sieger, B | 1 |
| Arrouet-Lagande, C; Ategbo, S; Deschildre, A; Druon, D; Husson, MO; Launay, V; Loeuille, GA; Sardet, A; Turck, D; Vic, P | 1 |
| Amorena, B; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Ategbo, S; Canis, F; Husson, MO; Trivier, D; Turck, D; Vic, P | 1 |
| Blumer, J; Green, M; Morrissey, A; Spinner-Block, S; Toltzis, P; Vilt, L; Yamashita, T | 1 |
| Caron, F | 1 |
| Abe, T; Fukuda, M; Hirashima, K; Karasawa, M; Miura, Y; Moriyama, Y; Motoyoshi, K; Nagata, N; Naruse, T; Ninomiya, H; Oh, H; Saito, K; Shibata, A; Shishido, H; Yoshida, M | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Hubbard, RW; Slocum, R | 1 |
| Bowler, SD; McCormack, JG; Wolter, JM | 1 |
| Dan, K; Furuya, T; Harada, Y; Hirosawa, S; Ikeda, Y; Kawaguchi, M; Kawamata, N; Kawano, K; Kikuchi, M; Matsuoka, S; Murakami, H; Onozawa, Y; Oshimi, K; Sawanobori, M; Shirota, T; Suzuki, K; Takeuchi, J; Tomoyasu, S; Toyama, K; Tsuruoka, N; Uchida, Y; Wakasugi, K; Yaguchi, M; Yamada, T; Yamamoto, K | 1 |
| Po, AL; Scott, EM; Tariq, VN; Wu, YL | 1 |
| Ahuja, R; Panda, A; Sastry, SS | 1 |
| Bailie, GR; Frye, R; Hess, LD; Manley, HJ; McGoldrick, MD | 1 |
| Martín, M; Mateu, E | 1 |
| Bonapace, CR; Bosso, JA; Friedrich, LV; White, RL | 1 |
| Dhert, WJ; Fleer, A; Nijhof, MW; Schouls, LM; Stallmann, HP; Verbout, AJ; Vogely, HC | 1 |
| Geraedts, AA; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF | 1 |
| Gómez Navalón, LA; López Alonso, A; Salido Valle, JA | 1 |
| Baghurst, PA; Colebatch, KA; Coulthard, KP; Hansman, D; Holmes, M; Jarvinen, A; Kennedy, D; Linke, RJ; Martin, A; Martin, AJ; Master, V; Onishko, CR; Parsons, DW; Roberts, GW; Roberts, ME | 1 |
| Lacy, MK; McNabb, J; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Barnhill, MA; Hendrix, DV; Ward, DA | 1 |
| Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Bailie, GR; Crawford, TL; Diaz-Buxo, JA | 1 |
| Ljungberg, B; Nilsson-Ehle, I; Nyhlén, A; Odenholt, I | 1 |
| Antosiewicz, S; Baczyński, D; Pietrzak, B; Wańkowicz, Z | 1 |
| Adriensen, B; Husson, MO; Loiez, C; Massoni-Cristante, S | 1 |
| Jones, RN; Rhomberg, PR | 1 |
| Ariano, RE; Harding, GK; Strijack, C; Zelenitsky, SA | 1 |
| Bugnon, D; Caillon, J; Gras-Le Guen, C; Jacqueline, C; Kergueris, MF; Navas, D; Potel, G | 1 |
| Huang, V; Rybak, MJ | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Kedzia, WB; Mirska, I | 1 |
| Leppänen, H; Metsärinne, KP; Nikoskelainen, J; Tertti, R | 1 |
| Eagye, KJ; Kuti, JL; Nicasio, AM; Nicolau, DP; Palter, M; Pepe, J; Shore, E | 1 |
| Otuk, G; Ozbek, B | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
| Burd, EM; Ribner, BS; Shak, JR; Whitaker, JA | 1 |
| Davis, GA; Feola, DJ; Hayes, D; Kuhn, RJ; Murphy, BS | 1 |
| Bosso, JA; Church, EC; Mauldin, PD | 1 |
| Bahniuk, N; Bonomo, RA; Brown, D; Bulitta, JB; Defiglio, H; Drawz, SM; Drusano, GL; Fikes, S; Kulawy, R; Louie, A; Vanscoy, B | 1 |
| Cuthbertson, BH; Daneman, N; Fowler, RA; Sarwar, S | 1 |
| Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Monogue, ML; Nicolau, DP | 1 |
| LeCleir, LK; Pettit, RS | 1 |
| Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
| Galega, R; Greene, JN; Lee, GC; Quilitz, R; Shurko, J; So, W | 1 |
| Avery, LM; Nicolau, DP; Sutherland, CA | 1 |
| Bonten, MJM; Bruijning-Verhagen, PC; de Smet, AMGA; de Wit, GA; Oostdijk, EAN; Plantinga, NL; van Hout, D; van Werkhoven, CH | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
| Agyeman, AA; Boyce, JD; Bulitta, JB; Cortés-Lara, S; Figuerola, J; Fraile-Ribot, P; Franklyn, ERT; Gomis-Font, MA; Landersdorfer, CB; Lang, Y; Lee, WL; López-Causapé, C; Lucas, DD; Nation, RL; Oliver, A; Rogers, KE; Zhang, Y; Zhou, J | 1 |
| Albur, M; Attwood, M; Griffin, P; Macgowan, AP; Noel, AR | 1 |
15 review(s) available for cephalosporin c and tobramycin
| Article | Year |
|---|---|
Recent advances in antimicrobial therapy.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Humans; Metronidazole; Sisomicin; Spectinomycin; Sulfamethoxazole; Ticarcillin; Tobramycin; Trimethoprim | 1977 |
Newer antibacterial and antimycotic drugs. Critical appraisal.
Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Clindamycin; Flucytosine; Humans; Imidazoles; Penicillins; Rifampin; Spectinomycin; Sulfamethoxazole; Tetracyclines; Tobramycin; Trimethoprim | 1978 |
Antibacterial Drugs today: II.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Cephradine; Framycetin; Gentamicins; Humans; Kanamycin; Neomycin; Paromomycin; Polymyxins; Streptomycin; Tobramycin | 1975 |
Empiric therapy of febrile granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin | 1979 |
[Antibiotics combination cefradin-tobramycin for the treatment of severe infections in trauma surgery].
Topics: Anti-Bacterial Agents; Burns; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Therapy, Combination; Emergency Medical Services; Fractures, Open; Humans; Infections; Osteomyelitis; Pneumonia; Surgical Wound Infection; Tobramycin; Urinary Tract Infections | 1979 |
Recent advances in antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Flucytosine; Gentamicins; Metronidazole; Penicillins; Plasmids; Sisomicin; Tobramycin | 1976 |
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1986 |
Antimicrobial therapy and the neonate.
Topics: Absorption; Aging; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Biotransformation; Cephalosporins; Chloramphenicol; Gentamicins; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kidney; Penicillins; Protein Binding; Tobramycin | 1981 |
Drug-induced sudden hearing loss and vestibular disturbances.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Diuretics; Female; Gentamicins; Guinea Pigs; Hearing Loss, Sudden; Humans; Maternal-Fetal Exchange; Pregnancy; Rats; Tobramycin; Vestibule, Labyrinth | 1981 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Eradication of Pseudomonas aeruginosa in an adult patient with cystic fibrosis.
Topics: Adult; Anti-Infective Agents; Cefepime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2011 |
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clinical Trials as Topic; Cross Infection; Decontamination; Digestive System; Disease Transmission, Infectious; Drug Resistance, Bacterial; Enterobacteriaceae; Europe; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Neomycin; Nystatin; Odds Ratio; Oropharynx; Polymyxins; Prevalence; Primary Prevention; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; South Africa; Tobramycin; United States; Vancomycin | 2013 |
Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis.
Topics: Administration, Topical; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Carrier State; Cephalosporins; Colistin; Cost-Benefit Analysis; Cross Infection; Decontamination; Drug Resistance, Microbial; Female; Gastrointestinal Tract; Health Care Costs; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Netherlands; Oropharynx; Randomized Controlled Trials as Topic; Tobramycin | 2019 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
38 trial(s) available for cephalosporin c and tobramycin
| Article | Year |
|---|---|
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients.
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Tobramycin | 1979 |
Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Random Allocation; Tobramycin | 1985 |
Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Pseudomonas; Pseudomonas aeruginosa; Sputum; Tobramycin | 1985 |
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Streptococcal Infections; Tobramycin; Urinary Tract Infections | 1983 |
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Topics: Abdomen; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Moxalactam; Nutrition Disorders; Prognosis; Random Allocation; Staphylococcal Infections; Staphylococcus; Tobramycin | 1983 |
Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin.
Topics: Aged; Anti-Bacterial Agents; Aspartate Aminotransferases; Ceftazidime; Cephalosporins; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Tobramycin; Urinary Tract Infections | 1983 |
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema.
Topics: Adult; Cefamandole; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Empyema; Escherichia coli Infections; Female; Gallbladder Diseases; Humans; Male; Prospective Studies; Tobramycin | 1983 |
Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
Topics: Adolescent; Adult; Carbenicillin; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Penicillin Resistance; Prospective Studies; Pseudomonas Infections; Random Allocation; Respiratory Function Tests; Respiratory Tract Infections; Tobramycin | 1983 |
Ceftazidime as a single agent in the management of children with fever and neutropenia.
Topics: Adolescent; Agranulocytosis; Anemia, Aplastic; Azlocillin; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neoplasms; Neutropenia; Penicillins; Random Allocation; Tobramycin | 1983 |
A comparative study of the efficacy of ceftazidime versus cefazolin and tobramycin in patients with acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bronchitis; Cefazolin; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Time Factors; Tobramycin | 1983 |
A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Escherichia coli Infections; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections | 1983 |
Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study.
Topics: Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Tobramycin; Urinary Tract Infections | 1983 |
A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia.
Topics: Adult; Aged; Bacterial Infections; Cefazolin; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combination; Hospitalization; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Clindamycin; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Tobramycin | 1983 |
Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G.
Topics: beta 2-Microglobulin; Cefuroxime; Cephalosporins; Chromium Radioisotopes; Drug Interactions; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Function Tests; Penicillin G; Prospective Studies; Random Allocation; Tobramycin | 1983 |
Comparative studies of antibiotic therapy after penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Cefoxitin; Cephalosporins; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation; Time Factors; Tobramycin; Wound Infection; Wounds, Gunshot; Wounds, Stab | 1984 |
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Methicillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1983 |
A prospective random study of a single agent versus combination antibiotics as therapy in penetrating injuries of the abdomen.
Topics: Abdominal Injuries; Adolescent; Adult; Anti-Bacterial Agents; Cefamandole; Cephalosporins; Cephalothin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Tobramycin; Wound Infection; Wounds, Penetrating | 1983 |
Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cephalosporins; Clinical Trials as Topic; Gentamicins; Humans; Middle Aged; Pyelonephritis; Tobramycin | 1980 |
Clinical and bacteriological results in urinary tract infections with single-dose Ro 13-9904 (Rocephin).
Topics: Aged; Bacterial Infections; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Tobramycin; Urinary Tract Infections | 1981 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Cornea; Corneal Ulcer; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Tobramycin; Treatment Outcome | 1995 |
Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta 2-Microglobulin; Biomarkers; Cefotaxime; Cephalosporins; Creatinine; Dipeptidyl Peptidase 4; Humans; Infant, Newborn; Prospective Studies; Tobramycin | 1995 |
Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bayes Theorem; Ceftazidime; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Models, Statistical; Reference Values; Sampling Studies; Tobramycin | 1996 |
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefazolin; Cephalosporins; Child; Ciprofloxacin; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tobramycin | 1996 |
Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis; Tobramycin | 1997 |
Comparative trial of four antibiotic combinations for perforated appendicitis in children.
Topics: Adolescent; Amebicides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Appendicitis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Intestinal Perforation; Male; Ornidazole; Penicillins; Piperacillin; Prospective Studies; Rupture, Spontaneous; Tobramycin; Treatment Outcome | 1997 |
Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Prospective Studies; Respiratory Tract Infections; Thienamycins; Time Factors; Tobramycin | 1997 |
A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Drug Therapy, Combination; Female; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Teicoplanin; Tobramycin; Treatment Outcome | 1997 |
Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Pseudomonas Infections; Sputum; Statistics, Nonparametric; Tobramycin | 1998 |
[Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
Topics: Adolescent; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Pneumonia, Bacterial; Pseudomonas Infections; Tobramycin | 1998 |
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Lenograstim; Leukocyte Count; Male; Middle Aged; Neutropenia; Pneumonia; Recombinant Proteins; Tobramycin; Treatment Outcome | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin | 1999 |
[Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infections; Male; Middle Aged; Sepsis; Tobramycin | 1999 |
Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcal Infections; Tobramycin; Visual Acuity | 1999 |
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome | 2001 |
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Safety; Tobramycin | 2001 |
142 other study(ies) available for cephalosporin c and tobramycin
| Article | Year |
|---|---|
Newer antibiotics: guidelines for use.
Topics: Amoxicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Clindamycin; Doxycycline; Drug Combinations; Gentamicins; Humans; Minocycline; Rifampin; Spectinomycin; Sulfamethoxazole; Tobramycin; Trimethoprim | 1976 |
New antibiotics and old diseases.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Humans; Penicillin Resistance; Spectinomycin; Sulfonamides; Tobramycin; Trimethoprim | 1977 |
[Combination of methylmethacrylate (acrylic cement) and antibiotics. Bacteriologic and mechanical study].
Topics: Ampicillin; Anti-Bacterial Agents; Biomechanical Phenomena; Cephalosporins; Chemical Phenomena; Chemistry; Chloramphenicol; Elasticity; Escherichia coli; Gentamicins; Hardness; Hip Joint; Humans; Joint Prosthesis; Methylmethacrylates; Penicillins; Staphylococcus aureus; Tobramycin | 1977 |
Management of bacterial infections in severely neutropenic subjects.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalosporins; Child; Drug Therapy, Combination; Humans; Neutropenia; Penicillin Resistance; Tobramycin | 1977 |
[Azlocilline and HR 756 in urosepsis and urinary tract infection with multiresistant pseudomonas and proteus morganii].
Topics: Adolescent; Cephalosporins; Female; Humans; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1979 |
A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefamandole; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Gentamicins; Haemophilus influenzae; Tobramycin | 1977 |
Alteration of effectiveness of antibiotics by anaerobiosis.
Topics: Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephalothin; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Metabolism; Microbial Sensitivity Tests; Proteus mirabilis; Tobramycin | 1977 |
Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cephalosporins; Drug Therapy, Combination; Endometritis; Escherichia coli Infections; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Proteus Infections; Proteus vulgaris; Pyelonephritis; Sepsis; Tobramycin | 1978 |
In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Cefamandole; Cephalosporins; Drug Synergism; Enterobacter; Escherichia coli; Gentamicins; Haemophilus influenzae; In Vitro Techniques; Klebsiella; Proteus; Staphylococcus aureus; Tobramycin | 1979 |
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens; Tobramycin | 1979 |
[In-vitro effect of tobramycin].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1977 |
Effect of prophylactic antibiotics in radical head and neck surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Cephalexin; Cephalosporins; Female; Gentamicins; Head and Neck Neoplasms; Humans; Male; Middle Aged; Postoperative Complications; Premedication; Surgical Wound Infection; Tobramycin | 1979 |
[Therapy of pyelonephritis].
Topics: Amikacin; Amoxicillin; Ampicillin; Carbenicillin; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Nalidixic Acid; Penicillin Resistance; Pivampicillin; Pyelonephritis; Sulfonamides; Tetracyclines; Tobramycin; Trimethoprim | 1977 |
Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
Topics: Adolescent; Aeromonas; Aged; Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Corynebacterium Infections; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Flavobacterium; Humans; Listeriosis; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Sepsis; Tobramycin | 1978 |
Aminoglycoside and cephalosporin toxicity.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Kidney Diseases; Tobramycin | 1978 |
[Bacteriological studies in outpatients with acute urinary tract infections with particular reference to the resistance spectrum (author's transl)].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cephalosporins; Escherichia coli; Gentamicins; Humans; Klebsiella; Nalidixic Acid; Nitrofurantoin; Penicillin Resistance; Proteus mirabilis; Tobramycin; Trimethoprim; Urinary Tract Infections | 1976 |
Effect of cefamandole nafate on the toxicity of tobramycin.
Topics: Animals; Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Interactions; Female; Lethal Dose 50; Mice; Mice, Inbred ICR; Rats; Time Factors; Tobramycin | 1977 |
[Treatment of septicemia and severe infections with a cefradine-tobramycin combination].
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephradine; Drug Combinations; Humans; Kidney; Sepsis; Tobramycin | 1976 |
[Drug sensitivity of Yersinia enterocolitica and Yersinia pseudotuberculosis].
Topics: Amikacin; Animals; Antibiotics, Antitubercular; Cephalosporins; Chloramphenicol; Dogs; Gentamicins; Humans; Kanamycin; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Tetracyclines; Tobramycin; Yersinia | 1976 |
Newer antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephapirin; Cephradine; Clindamycin; Drug Combinations; Gastrointestinal Diseases; Humans; Minocycline; Penicillins; Respiratory Tract Infections; Sexually Transmitted Diseases; Sulfamethoxazole; Tobramycin; Trimethoprim; Urinary Tract Infections | 1975 |
[Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Topics: Adult; Aged; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Tobramycin | 1992 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
Cranioplasty, vertebral body replacement, and spinal fusion with tobramycin-impregnated methylmethacrylate.
Topics: Bacterial Infections; Bone Cements; Cephalosporins; Drug Implants; Follow-Up Studies; Humans; Methylmethacrylate; Methylmethacrylates; Nafcillin; Premedication; Prospective Studies; Prostheses and Implants; Skull; Spinal Fusion; Spine; Tobramycin | 1991 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1989 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Chequerboard titrations: the influence of the composition of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index.
Topics: Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Interactions; Humans; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1987 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefepime; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Hydrolysis; Microbial Sensitivity Tests; Tobramycin | 1986 |
Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
Topics: Cephalosporins; Drug Interactions; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Staphylococcus aureus; Tobramycin | 1986 |
In vitro inactivation of tobramycin by cephalosporins.
Topics: Cephalosporins; Drug Combinations; Fluorescent Antibody Technique; Humans; In Vitro Techniques; Temperature; Time Factors; Tobramycin | 1985 |
[Recent advances in injectable antibiotics].
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Injections, Intramuscular; Polymyxins; Tobramycin | 1974 |
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin | 1984 |
Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers.
Topics: Adult; Aminopeptidases; Anti-Bacterial Agents; CD13 Antigens; Ceftazidime; Cell Membrane; Cephalosporins; Humans; Kidney; Kidney Function Tests; Kidney Tubules, Proximal; Male; Tobramycin | 1983 |
Enzymuria: a parameter for the assessment of potential nephrotoxicity of cephalosporins.
Topics: Adult; Aminopeptidases; CD13 Antigens; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Humans; Kidney; Male; Tobramycin | 1983 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1982 |
Antibiotic penetration in abdominal infection: a case of tobramycin failure responsive to moxalactam.
Topics: Abdomen; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications; Tobramycin | 1983 |
Cefoperazone-aminoglycoside incompatibility.
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Incompatibility; Gentamicins; Tobramycin | 1983 |
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Male; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 1983 |
Sensitivity testing and synergy.
Topics: Azlocillin; Bacteria; Cefotaxime; Cephalosporins; Culture Media; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Tobramycin | 1980 |
[Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cefazolin; Cefotaxime; Ceftizoxime; Cephalosporins; Humans; Respiratory Tract Infections; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections | 1982 |
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Half-Life; Humans; Kinetics; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Tobramycin | 1983 |
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
Topics: Adolescent; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Sulfamethoxazole; Tobramycin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Ceftazidime - a significant advance in the treatment of cystic fibrosis.
Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Tobramycin | 1983 |
Ceftazidime in the treatment of febrile immunosuppressed children.
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neutropenia; Pilot Projects; Staphylococcal Infections; Tobramycin | 1983 |
Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Fever; Hematologic Diseases; Humans; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Tobramycin | 1983 |
Ceftazidime nephrotoxicity in rats.
Topics: Animals; Ceftazidime; Cephalosporins; Creatinine; Kidney Diseases; Male; Osmolar Concentration; Proteinuria; Rats; Rats, Inbred Strains; Tobramycin | 1984 |
Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.
Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1983 |
Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefsulodin; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1984 |
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Topics: Agranulocytosis; Aminoglycosides; Animals; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Netilmicin; Neutropenia; Penicillin Resistance; Penicillins; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1984 |
A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefamandole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Tobramycin | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
Procedure for assay of tobramycin in serum containing moxalactam.
Topics: Anti-Bacterial Agents; Bacillus cereus; Bacillus subtilis; Biological Assay; Cephalosporinase; Cephalosporins; Cephamycins; Humans; Hydrolysis; Moxalactam; Tobramycin; Zinc | 1981 |
Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Bacterial Infections; Cefmetazole; Cephalosporins; Cephamycins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Penicillins; Piperacillin; Tobramycin | 1981 |
[Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Cephalosporins; Cephamycins; Drug Synergism; Furosemide; Kidney; Kidney Diseases; Liver; Male; Moxalactam; Organ Size; Rabbits; Tobramycin | 1981 |
In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Tobramycin | 1984 |
Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.
Topics: Adult; Anti-Bacterial Agents; Carbenicillin; Cefsulodin; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Peak Expiratory Flow Rate; Pseudomonas Infections; Tobramycin | 1983 |
Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Interactions; Gentamicins; Humans; Penicillins; Tobramycin | 1983 |
[Klebsiella pneumonia].
Topics: Adult; Cefuroxime; Cephalosporins; Humans; Klebsiella pneumoniae; Male; Pneumonia; Tobramycin | 1980 |
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[3d generation cephalosporins in nosocomial infections].
Topics: Adolescent; Adult; Aged; Azlocillin; Cephalosporins; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Tobramycin | 1983 |
[Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Topics: Anti-Bacterial Agents; Cefamandole; Cephalosporins; Drug Therapy, Combination; Humans; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin | 1982 |
In vitro interactions between beta-lactam antibiotics and tobramycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cold Temperature; Drug Stability; Kinetics; Penicillinase; Penicillins; Tobramycin | 1981 |
[Cefuroxime-tobramycin treatment of bacterial infections in cancer patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Meningitis, Meningococcal; Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus agalactiae; Tobramycin | 1980 |
[Effectiveness of the combined use of tobramycin with carbenicillin or cephalosporins in experimental infection in mice caused by Providencia stuartii].
Topics: Animals; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Drug Evaluation, Preclinical; Drug Therapy, Combination; Mice; Microbial Sensitivity Tests; Proteus Infections; Providencia; Tobramycin | 1982 |
Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Gentamicins; Microbial Sensitivity Tests; Peritoneal Dialysis; Solutions; Tobramycin | 1982 |
Differences among Providencia species in their in vitro susceptibilities to five antibiotics.
Topics: Anti-Bacterial Agents; Cephalosporins; Gentamicins; Microbial Sensitivity Tests; Proteus; Providencia; Tobramycin | 1980 |
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefamandole; Cefoxitin; Cephalosporins; Gentamicins; Humans; Methods; Tobramycin | 1981 |
[Annual number of Pseudomonas aeruginosa isolated inpatients, and antibacterial activity of various antibiotics against P. aeruginosa isolated from clinical specimens of inpatients].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Humans; Inpatients; Pseudomonas aeruginosa; Tobramycin | 1995 |
Osteomyelitis of the spine due to Salmonella: case report, review of clinical aspects, pathogenesis and treatment.
Topics: Anemia, Sickle Cell; Cephalosporins; Chloramphenicol; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Humans; Immune System Diseases; Lumbar Vertebrae; Male; Middle Aged; Psoas Abscess; Salmonella Infections; Salmonella typhimurium; Spondylitis; Therapeutic Irrigation; Tobramycin; Tomography, X-Ray Computed | 1993 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Clinical Trials as Topic; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Tobramycin | 1996 |
Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clostridioides difficile; Colon; Diarrhea; Fatty Acids, Volatile; Female; Humans; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Nystatin; Tobramycin | 1996 |
Erythema-multiforme-like eruption from antibiotics of 3 different groups.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephalothin; Clindamycin; Drug Eruptions; Erythema Multiforme; Female; Humans; Lincomycin; Middle Aged; Tobramycin | 1996 |
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
Topics: Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
AUIC--a general target for the optimization of dosing regimens of antibiotics?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefmenoxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Models, Biological; Tobramycin | 1996 |
Listeria meningitis during treatment of a meningococcal meningitis in an immunocompetent infant.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Child, Preschool; Drug Therapy, Combination; Female; Humans; Immunocompetence; Listeria monocytogenes; Meningitis, Listeria; Meningitis, Meningococcal; Penicillin G; Penicillins; Tobramycin | 1996 |
The disposition of five therapeutically important antimicrobial agents in llamas.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biological Availability; Camelids, New World; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Overdose; Drug Residues; Enrofloxacin; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Penicillins; Quinolones; Software; Sulfamethoxazole; Tissue Distribution; Tobramycin; Trimethoprim | 1996 |
Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1997 |
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1996 |
Catalase-negative Listeria monocytogenes causing lethal sepsis and meningitis in an adult hematologic patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Blotting, Western; Catalase; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Diagnosis, Differential; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Female; Humans; Listeria monocytogenes; Lymphoma, T-Cell, Cutaneous; Meningitis, Listeria; Penicillins; Polymerase Chain Reaction; Sepsis; Tobramycin | 1996 |
Combined peribulbar and retrobulbar block anesthesia and antibiotic-steroid injection: a simple method to prevent retrobulbar hemorrhage, globe perforation, or infection.
Topics: Anesthesia, Local; Anesthetics, Local; Anti-Bacterial Agents; Betamethasone; Cephalosporins; Drug Therapy, Combination; Eye Infections; Eye Injuries, Penetrating; Glucocorticoids; Humans; Injections; Needlestick Injuries; Nerve Block; Orbit; Retrobulbar Hemorrhage; Tobramycin | 1997 |
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1997 |
Is it possible to prevent bacterial adhesion onto ureteric stents?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Bacteriological Techniques; Ceftriaxone; Cephalosporins; Ciprofloxacin; Escherichia coli; Humans; Materials Testing; Stents; Tobramycin; Ureter; Urinary Tract Infections | 1997 |
[Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Tobramycin | 1997 |
Pharmacodynamic parameters of ofloxacin, tobramycin and ceftriaxone and their effect on the biological properties of salmonellae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Coloring Agents; Congo Red; Microbial Sensitivity Tests; Ofloxacin; Salmonella; Salmonella enteritidis; Salmonella Phages; Salmonella typhimurium; Tobramycin | 1997 |
Predictive value of several signs of infection as surrogate markers for mortality in a neutropenic guinea pig model of Pseudomonas aeruginosa sepsis.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss | 1997 |
Corneal ulcer associated with contamination of aerosol saline spray tip.
Topics: Aerosols; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Chloride; Tobramycin | 1997 |
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Drug Monitoring; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Penicillins; Prognosis; Tobramycin | 1998 |
Osteopetrosis complicated by osteomyelitis of the mandible: a case report including gross and microscopic findings.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Susceptibility; Humans; Male; Mandible; Mandibular Diseases; Osteomyelitis; Osteopetrosis; Recurrence; Tobramycin | 1998 |
Storage of extemporaneously prepared ophthalmic antimicrobial solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Drug Compounding; Drug Storage; Ophthalmic Solutions; Tobramycin; Vancomycin | 1998 |
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1998 |
Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics.
Topics: Anti-Bacterial Agents; Area Under Curve; Ceftazidime; Cephalosporins; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Half-Life; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Tobramycin | 1998 |
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E | 1998 |
Meropenem monotherapy as empiric treatment of nosocomial lower respiratory tract infection.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Humans; Meropenem; Pneumonia, Bacterial; Severity of Illness Index; Thienamycins; Tobramycin; Treatment Outcome | 1998 |
Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cephalosporins; Male; Microbial Sensitivity Tests; Osteomyelitis; Predictive Value of Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1998 |
Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Chi-Square Distribution; Child; Contraindications; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Intensive Care Units, Pediatric; Microbial Sensitivity Tests; Nasopharynx; Rectum; Time Factors; Tobramycin | 1998 |
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin | 1995 |
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1999 |
Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Automation; Cefazolin; Cephalosporins; Dialysis Solutions; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Injections, Intravenous; Middle Aged; Peritoneal Dialysis; Tobramycin | 2000 |
Antimicrobial resistance in enteric porcine Escherichia coli strains in Spain.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Cephalosporins; Colistin; Diarrhea; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Nebramycin; Neomycin; Quinolones; Spain; Swine; Swine Diseases | 2000 |
Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Piperacillin; Reproducibility of Results; Tobramycin | 2000 |
Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthritis, Infectious; Blood Sedimentation; Bone Cements; Cefazolin; Cephalosporins; DNA, Bacterial; Drug Evaluation, Preclinical; Female; Femur; Injections, Intravenous; Materials Testing; Methylmethacrylate; Models, Animal; Polymerase Chain Reaction; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Weight Loss | 2000 |
In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.
Topics: Administration, Topical; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Decontamination; Digestive System; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymyxins; Tobramycin | 2000 |
[Alpha-1-antitrypsin in early infections after hip prosthesis surgery].
Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; alpha 1-Antitrypsin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Sedimentation; C-Reactive Protein; Cefamandole; Cephalosporins; Clinical Enzyme Tests; Data Interpretation, Statistical; Female; Hip Prosthesis; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Postoperative Care; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Tobramycin; Vancomycin | 2000 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Effects of antibiotics on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cell Movement; Cephalosporins; Chloramphenicol; Ciprofloxacin; Cornea; Culture Techniques; Dogs; Epithelial Cells; Gentamicins; Statistics, Nonparametric; Tobramycin | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Tobramycin | 2001 |
Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftazidime; Cephalosporins; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Etoposide; Fluorouracil; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Tobramycin | 2002 |
[Empirical therapy of peritonitis in peritoneal dialysis patients--it is reasonable to use a new therapeutic schedule?].
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalosporins; Cephradine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Poland; Retrospective Studies; Tobramycin; Treatment Outcome | 2002 |
[Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Topics: Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Meropenem; Microbial Sensitivity Tests; North America; Sensitivity and Specificity; Thienamycins; Tobramycin | 2003 |
Peritoneal fluid titer test for peritoneal dialysis-related peritonitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cephalosporins; Colony Count, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritonitis; Pilot Projects; Renal Dialysis; Reproducibility of Results; Tobramycin | 2004 |
Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 2004 |
Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Colony Count, Microbial; Drug Therapy, Combination; Gentamicins; Half-Life; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Tobramycin | 2005 |
Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
Topics: Amikacin; Bacillus; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1989 |
Three-year analysis of microbial aetiology and antimicrobial susceptibilities of PD peritonitis.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Dialysis Solutions; Female; Glucans; Glucose; Humans; Icodextrin; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Tobramycin; Vancomycin | 2006 |
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Observation; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2009 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
Topics: Adult; Aeromonas hydrophila; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Fresh Water; Humans; Male; Microbial Sensitivity Tests; Soft Tissue Infections; Tobramycin; Wounds and Injuries | 2011 |
Antibiotic resistance in Pseudomonas aeruginosa related to quinolone formulary changes: an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Formularies, Hospital as Topic; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2011 |
Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Western; Cefepime; Cephalosporins; Computer Simulation; Drug Administration Schedule; Drug Interactions; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tobramycin | 2012 |
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure | 2014 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Culture Media; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tobramycin; Treatment Outcome | 2016 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; Treatment Outcome | 2019 |
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States | 2019 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
Topics: Adolescent; Anti-Bacterial Agents; Biofilms; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin | 2023 |
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
Topics: Anti-Bacterial Agents; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin | 2023 |